Generic Name and Formulations:
Selegiline HCl 5mg; caps.
Somerset Pharmaceuticals, Inc.
Indications for ELDEPRYL:
Adjunct to levodopa/ carbidopa in Parkinsonism.
5mg at breakfast and at lunch; max 10mg/day. After 2–3 days, levodopa/ carbidopa dosage may be reduced by 10–30%; further reductions may be possible later.
Concomitant meperidine, other opioids (See Interactions).
Selectivity for MAO type B diminishes at doses over 10mg/day. Pregnancy (Cat.C). Nursing mothers: not recommended.
Contraindicated with meperidine, possibly other opioids (hyperpyretic crisis). Avoid concomitant tricyclic antidepressants or selective serotonin reuptake inhibitors (SSRIs). Allow at least 5 weeks (or more if used chronically or at high doses) between fluoxetine discontinuance and 2 weeks between paroxetine or sertraline discontinuance before starting selegiline; allow 2 weeks between selegiline discontinuance before starting tricyclic antidepressants or SSRIs. Caution with tyramine-containing foods and with sympathomimetics.
Nausea, dizziness, lightheadedness, syncope, abdominal pain, confusion, vivid dreams, hallucinations, dry mouth, headache.